Connect public, paid and private patent data with Google Patents Public Datasets

Two-stage electromagnetophoresis

Download PDF

Info

Publication number
US3567611A
US3567611A US3567611DA US3567611A US 3567611 A US3567611 A US 3567611A US 3567611D A US3567611D A US 3567611DA US 3567611 A US3567611 A US 3567611A
Authority
US
Grant status
Grant
Patent type
Prior art keywords
stage
sample
field
electromagnetophoresis
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
Inventor
Richard E Michel
Robert M Nalbandian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Motors Liquidation Co
Original Assignee
Motors Liquidation Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416Systems
    • G01N27/447Systems using electrophoresis
    • G01N27/44756Apparatus specially adapted therefor
    • G01N27/44786Apparatus specially adapted therefor of the magneto-electrophoresis type

Abstract

MATERIAL, SUCH AS HUMAN NORMAL BLOOD SERUM PROTEIN, IS PARTITIONED BY TWO-STAGE ELECTROMAGNETOPHORESIS AS A FUNCTION OF MOLECULAR PARAMAGNETISM. IN THE FIRST STAGE THE PROTEIN TO BE PARTITIONED IS POSITIONED ON A PRISM OF GEL AND IS ELECTROPHORESEL TO PROVIDE A FIRST PARTITION THEREOF IN THE DIRECTION OF THE APPLIED ELECTRIC FIELD IN ACCORDANCE WITH PHYSICAL AND ELECTRICAL CHARACTERISTIC THEREOF. FOLLOWING THE COMPLETION OF THE ELECTROPHORESIS, THE PRISM IS PLACED IN A NON-UNIFORM MAGNETIC FIELD AND MAGNETOPHORESED. THE PROTEINS SUSPENDED IN A PARTIONED STATE IN THE GEL MATRIX AS THE RESULT OF ELECTROPHORESIS ARE THUS PARTITIONED IN A DIRECTION PARALLEL TO THE MAGNETIC FIELD GRADIENT AS A FUNCTION OF THE PARAMAGNETISM OF THE MOLECULES OF THE PROTEIN.

Description

March 2, 1911 R. E MICHEL ETAL TWO-STAGE ELECTROMAGNETOPHORESIS Filed Sept. 16, 1968 l8- :4 no

United States Patent C) 3,567,611 TWO-STAGE ELECTROMAGNETOPHORESIS Richard E. Michel, Birmingham, and Robert M. Nalbandian, Bloomfield Hills, Mich.; said Michel assignor to General Motors Corporation, Detroit, Mich.

Filed Sept. 16, 1968, Ser. No. 759,884 Int. Cl. B01k 5/00 US. Cl. 204180 7 Claims ABSTRACT OF THE DISCLOSURE Material, such as human normal blood serum protein, is partitioned by two-stage electromagnetophoresis as a function of molecular paramagnetism. In the first stage the protein to be partitioned is positioned on a prism of gel and is electrophoresed to provide a first partition thereof in the direction of the applied electric field in accordance with physical and electrical characteristics thereof. Following the completion of the electrophoresis, the prism is placed in a non-uniform magnetic field and magnetophoresed. The proteins suspended in a partitioned state in the gel matrix as the result of electrophoresis are thus partitioned in a direction parallel to the magnetic field gradient as a function of the paramagnetism of the molecules of the protein.

BACKGROUND OF THE INVENTION Field of the invention The invention relates to partitioning techniques and refers more specifically to a method of partitioning human normal serum protein or the like by two-stage electromagnetophoresis as a function of molecular paramagnetism in which a material sample is electrophoresed and then magnetophoresed to provide displacement and grouping of molecules in accordance with their physical and electrical properties.

Description of the prior art In the past physical partitioning of material samples has been carried out in laboratories by known methods, such as chromatography, electrophoresis which has been done in many ways, ultra-centrifugation, counter-current separation, density gradient separation, dialysis, and the like. Simultaneous electromagnetophoresis has also been attempted in the past, however the separation arose from the force on a charged particle moving in a magnetic field. It is not believed that two-stage electromagnetophoretic partition of human normal serum protein or the like has been previously attempted.

SUMMARY OF THE INVENTION In accordance with the invention, two-stage electromagnetophoresis is accomplished by the method of first placing a sample of material to be partitioned on a gel prism and electrophoresing the sample, in a first stage, to provide a first partition thereof in accordance with the physical and electrical properties of the sample. The electrophoresed sample is then placed in a non-uniform magnetic field and magnetophoresed, in a second stage, to provide further partition of the sample in accordance with the paramagnetism of the molecules of the sample. The partition of the sample in the second stage is parallel to the magnetic field gradient.

The observed partition due to differential paramagnetic properties of the human normal serum proteins is another parameter by which isolation and characterization of the proteins is possible.

3,567,151 1 Patented Mar. 2, 1971 FIG. 1 is a top view of structure for accomplishing twostage electromagnetophoresis in accordance with the method of the invention.

FIG. 2 is a side view of the structure illustrated in FIG. 1.

FIG. 3 is a side view of structure for accomplishing electrophoresis in a standard procedure which has been done in many ways.

'FIG. 4 is a top view of structure for accomplishing the second stage of two-stage electromagnetophoresis in accordance with the method of the invention.

FIG. '5 is a side view of the structure illustrated in FIG. 4.

FIG. 6 is a pictorial illustration of the results of twostage electromagnetophoresis practiced by the method of the invention.

FIG. 7 is a pictorial illustration of a control sample useful in illustrating the difierence of two-stage electromagnetophoresis in comparison with electrophoresis alone.

DESCRIPTION OF THE PREFERRED EMBODIMENT In accordance with the method of the invention twostage electromagnetophoresis is accomplished by first filling a transparent plastic chamber 10, open at both ends, with a polyacrylamide gel 12. No spacer gel is used. Sodium persulfate is used to induce polymerization.

The method of providing the gel is fully set forth by Ornstein and Davis in their work, Disc Electrophoresis I, Background and Theory, Ann. N.Y. Acad. Sci. 121 :321-403, 1964, and Disc Electrophoresis II. Method and Application to Human Serum Proteins, Ann. N.Y. Acad. Sci. 121:404-436, 1964, respectively.

At one side on the top surface of the rectangular prism of gel 12 in a slight depression 0.1 to 0.2 ml. of human normal serum protein 14 is deposited. The system is then electrophoresed through use of the electrical apparatus 16 for thirty to forty-five minutes using a current of thirty milliamperes with a voltage range of volts to 320 volts delivered by a variable voltage power supply as a source of direct current.

Following the completion of the electrophoresis or first stage, the plastic chamber 10 with the gel 12 therein is placed for one hour in a non-uniform magnetic field generated by the electromagnet structure 18 where it is magnetophoresed. Typical values of the product of the magnetic field times the magnetic field gradient for the magnetophoresis, or second stage of the two-stage electromagnetophoresis, may be about twenty-five times 10 oersteds per centimeter squared.

As the result of the first stage or electrophoresis the human normal blood protein is separated vertically of the gel 12 in the chamber 10 into a plurality of separate layers of molecules having difierent physical and electrical properties, as shown diagrammatically in FIG. 3. The separation of the protein sample is evident when the gel is stained with a 0.1% amido-black solution and destained electrophoretically, as has been known in the past. A control sample of electrophoresed but not magnetophoresed protein is illustrated pictorially in FIG. 7.

Subsequent magnetophoresing of the electrophoresed protein sample produces movement of the partitioned protein sample suspended in the gel matrix parallel to the magnetic field gradient in which the gel is placed. The movement of the partitioned protein sample appears to be a function of paramagnetism of the individual molecules. Thus, the paramagnetic molecules undergo linear displacement in the non-uniform magnetic field (an established physical principle) whereby the serum sample is again partitioned, as shown pictorially in FIG. 6.

The partitioning of sample material by the method of two-stage electromagnetophoresis thereof is useful in diagnostic medical applications. For example, diagnosis of hemoglobinopathies and dysproteinemias may be possible using the two-stage electromagnetophoresis technique disclosed.

Two-stage electromagnetophoresis also may aid in physical partition problems occurring in biology and in the technology of the chemical and pharmaceutical industries. In addition, it is anticipated that in a more fundamental sense correlation will be found between new information about the structure of protein molecules resulting from two-stage electromagnetophoresis and avariety of diseases.

It is anticipated that the two-stage electromagnetophoresis disclosed herein may be used as a basic partition technique for other molecular systems (paramagnetic molecules with electrical charges) for which human normal serum proteins may be considered merely a general model. It is the intention to include all embodiments and modifications of the method of partition by electromagnetophoresis as are defined by the appended claims within the scope of the invention.

We claim:

1. The method of physical molecular partition, comprising separating a material sample by electrophoresis within a matrix in accordance with molecular physical and electrical properties thereof and additionally separating the sample by magnetophoresis within said matrix by placing it in a non-uniform magnetic field to produce movement of the molecules in a direction parallel to the magnetic field gradient in accordance with paramagnetism of the molecules thereof.

2. The method as set forth in claim 1 wherein the electrophoresis and magnetophoresis are carried out in two distinct and separate stages.

3. The method as set forth in claim 2 wherein the sample is electrophoresed before it is magnetophoresed.

4. The method as set forth in claim 1 wherein the material sample is human normal blood serum protein and the electrophoresis is accomplished in a polyacrylamide gel.

5. The method as set forth in claim 4 wherein the human normal blood serum protein is electrophoresed for thirty to forty-five minutes, using a current of approximately thirty milliamperes and a voltage variable between and 320 volts.

6. The method as set forth in claim 1 wherein the magnetic field is such that the product of the magnetic field strength times the magnetic field gradient is approximately times 10 oersteds per centimeter.

7. The method as set forth in claim 6 wherein the electrophoresed sample is placed in the non-uniform magnetic field for approximately one hour.

References Cited UNITED STATES PATENTS 3,140,714 7/1964 Murphy, Jr. et a1. 128214 3,207,684 9/1965 Dotts, Jr. 204 3,451,918 6/1969 Kolin 204299 3,479,277 11/1969 Kolin et a1 204299 OTHER REFERENCES Markham, A Modified Method of Two-Dimensional Zone Electrophoresis Applied to Mucoproteins in Serum and Urine, Nature, 17714499, pp. 125-126, Jan. 21, 1956.

JOHN H. MACK, Primary Examiner A. C. PRESCOTT, Assistant Examiner US. Cl. XvR- 204299

US3567611A 1968-09-16 1968-09-16 Two-stage electromagnetophoresis Expired - Lifetime US3567611A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US75988468 true 1968-09-16 1968-09-16

Publications (1)

Publication Number Publication Date
US3567611A true US3567611A (en) 1971-03-02

Family

ID=25057319

Family Applications (1)

Application Number Title Priority Date Filing Date
US3567611A Expired - Lifetime US3567611A (en) 1968-09-16 1968-09-16 Two-stage electromagnetophoresis

Country Status (1)

Country Link
US (1) US3567611A (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3988230A (en) * 1973-12-31 1976-10-26 Medac Gesellschaft Fur Klinische Spezial Praparate Mbh Chamber and process for crossed immunoelectro-phoresis
US3989612A (en) * 1974-12-26 1976-11-02 The Upjohn Company Elution device for gel electrophoresis
US4094759A (en) * 1975-01-03 1978-06-13 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Method for simultaneous quantitative analysis of several constituents in a sample
US4146454A (en) * 1970-12-28 1979-03-27 Haber Instruments, Inc. Electromolecular propulsion in diverse semiconductive media
US4148703A (en) * 1976-02-11 1979-04-10 Morton Weintraub Method of electrophoretic purification of enzymes and peptides by means of an adjustable, specialized, geometrically located electrode system
US4385974A (en) * 1982-06-24 1983-05-31 Jerry Shevitz Electrophoretic system and method for multidimensional analysis
US4693804A (en) * 1984-12-19 1987-09-15 Board Of Regents, The University Of Texas System Apparatus for bidimensional electrophoretic separations
US5167790A (en) * 1985-09-27 1992-12-01 Washington University Field-inversion gel electrophoresis
US5185071A (en) * 1990-10-30 1993-02-09 Board Of Regents, The University Of Texas System Programmable electrophoresis with integrated and multiplexed control
US5338687A (en) * 1992-09-11 1994-08-16 Lee Lawrence L Detection of biological macromolecules by NMR-sensitive labels
US5866303A (en) * 1997-10-15 1999-02-02 Kabushiki Kaisha Toshiba Resist developing method by magnetic field controlling, resist developing apparatus and method of fabricating semiconductor device
US20040203126A1 (en) * 2003-04-08 2004-10-14 Yokogawa Electric Corporation Method and apparatus for separating and purifying biopolymers

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146454A (en) * 1970-12-28 1979-03-27 Haber Instruments, Inc. Electromolecular propulsion in diverse semiconductive media
US3988230A (en) * 1973-12-31 1976-10-26 Medac Gesellschaft Fur Klinische Spezial Praparate Mbh Chamber and process for crossed immunoelectro-phoresis
US3989612A (en) * 1974-12-26 1976-11-02 The Upjohn Company Elution device for gel electrophoresis
US4094759A (en) * 1975-01-03 1978-06-13 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Method for simultaneous quantitative analysis of several constituents in a sample
US4148703A (en) * 1976-02-11 1979-04-10 Morton Weintraub Method of electrophoretic purification of enzymes and peptides by means of an adjustable, specialized, geometrically located electrode system
US4385974A (en) * 1982-06-24 1983-05-31 Jerry Shevitz Electrophoretic system and method for multidimensional analysis
US4693804A (en) * 1984-12-19 1987-09-15 Board Of Regents, The University Of Texas System Apparatus for bidimensional electrophoretic separations
US5167790A (en) * 1985-09-27 1992-12-01 Washington University Field-inversion gel electrophoresis
US5185071A (en) * 1990-10-30 1993-02-09 Board Of Regents, The University Of Texas System Programmable electrophoresis with integrated and multiplexed control
US5338687A (en) * 1992-09-11 1994-08-16 Lee Lawrence L Detection of biological macromolecules by NMR-sensitive labels
US5866303A (en) * 1997-10-15 1999-02-02 Kabushiki Kaisha Toshiba Resist developing method by magnetic field controlling, resist developing apparatus and method of fabricating semiconductor device
US6279502B1 (en) 1997-10-15 2001-08-28 Kabushiki Kaisha Toshiba Resist developing method by magnetic field controlling, resist developing apparatus and method of fabricating semiconductor device
US20040203126A1 (en) * 2003-04-08 2004-10-14 Yokogawa Electric Corporation Method and apparatus for separating and purifying biopolymers

Similar Documents

Publication Publication Date Title
Hjerten et al. Electrophoretic “particle sieving” in polyacrylamide gels as applied to ribosomes
Maizel Preparative electrophoresis of proteins in acrylamide gels
Robertson et al. Rapid isoelectric focusing in a vertical polyacrylamide minigel system
Hjerten et al. Theoretical and experimental study of high-performance electrophoretic mobilization of isoelectrically focused protein zones
Stenerlöw et al. Measurement of prompt DNA double-strand breaks in mammalian cells without including heat-labile sites: results for cells deficient in nonhomologous end joining
Bray et al. Unpolymerized actin in fibroblasts and brain
US4130470A (en) Method for generating a pH-function for use in electrophoresis
Li et al. Dielectrophoretic separation and manipulation of live and heat-treated cells of Listeria on microfabricated devices with interdigitated electrodes
Chang et al. Electrokinetically driven microfluidics and nanofluidics
Müller et al. A 3-D microelectrode system for handling and caging single cells and particles
Goldenberg et al. Gel electrophoresis in studies of protein conformation and folding
Gershoni et al. Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to a positively charged membrane filter
Ogita et al. A miniaturized system for electrophoresis on polyacrylamide gels
Schoenbach et al. Bioelectrics-new applications for pulsed power technology
Pethig Dielectrophoresis: using inhomogeneous AC electrical fields to separate and manipulate cells
Teorell Excitability phenomena in artificial membranes
US4465582A (en) Continuous flow electrophoresis apparatus
Wang et al. Dielectrophoretic manipulation of particles
Martonosi The protein composition of sarcoplasmic reticulum membranes
US4416761A (en) Multi slab gel casting electrophoresis apparatus
Robinson et al. Leukopoietic activity in human urine: the granulocytic leukemias
Ward et al. The production by antigen-stimulated lymphocytes of a leukotactic factor distinct from migration inhibitory factor
US3620947A (en) Electrophoretic system
Teng et al. Species-specific interactions between nuclear phosphoproteins and DNA
US6467630B1 (en) Continuous particle and molecule separation with an annular flow channel